BTG’s esophageal cancer gel fails in trial (Reuters)
Reuters – British pharmaceutical group BTG said its OncoGel treatment did not show any impact on tumors in patients with esophageal cancer and it would not seek a partner for the product.
View full post on Yahoo! News: Health News
Leave a Reply